Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
5 analysts have shared their evaluations of SS&C Techs Hldgs (NASDAQ:SSNC) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 1 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 2 | 1 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $70.0, a high estimate of $77.00, and a low estimate of $60.00. This upward trend is evident, with the current average reflecting a 8.02% increase from the previous average price target of $64.80.
The perception of SS&C Techs Hldgs by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Andrew Schmitt | Citigroup | Raises | Buy | $71.00 | $70.00 |
Kevin Mcveigh | UBS | Raises | Buy | $77.00 | $72.00 |
Daniel Perlin | RBC Capital | Raises | Outperform | $72.00 | $65.00 |
Michael Young | Truist Securities | Raises | Hold | $60.00 | $55.00 |
Mayank Tandon | Needham | Raises | Buy | $70.00 | $62.00 |
To gain a panoramic view of SS&C Techs Hldgs's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on SS&C Techs Hldgs analyst ratings.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in Virtual Data Room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services.
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: SS&C Techs Hldgs's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 3.35%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: SS&C Techs Hldgs's net margin excels beyond industry benchmarks, reaching 13.77%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): SS&C Techs Hldgs's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.11% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): SS&C Techs Hldgs's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.13% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: SS&C Techs Hldgs's debt-to-equity ratio is below the industry average at 1.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SSNC